Tianjin Huanhu Hospital
Clinical trials sponsored by Tianjin Huanhu Hospital, explained in plain language.
-
Engineered immune cells take on multiple sclerosis and myasthenia gravis in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with severe autoimmune diseases like multiple sclerosis, neuromyelitis optica, and myasthenia gravis. Up to 1…
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
Stroke breakthrough? albumin infusion after clot removal aims to boost brain recovery
Disease control Not yet recruitingThis study tests whether giving a dose of human albumin directly into the brain artery after a clot-removal procedure helps people recover more fully from a severe stroke. About 306 adults with large-vessel blockage strokes will be randomly assigned to receive either standard clo…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Could a simple protein boost help stroke patients recover?
Disease control Not yet recruitingThis study tests whether giving a protein called albumin directly into the brain's artery, right after a clot-removal procedure, can limit brain damage in people having a severe stroke. About 60 adults with large-vessel blockages will be randomly assigned to receive either standa…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 01, 2026 16:01 UTC